Washington, DC–On June 9, the FDA authorized for marketing Futura Medical Developments Limited’s Eroxon (MED3000), a non-medicated hydro-alcoholic gel indicated for treatment of erectile dysfunction in adult males aged 22 years and over.
Upon application, the volatile components of the formulation (alcohol and water) evaporate to create a rapid, localized cooling effect on the glans penis followed by a recovering slower warming effect. This stimulates the nerve endings leading to tumescence and erection.
This authorization marks the first over-the-counter gel intended to treat erectile dysfunction. It is learned that the gel is currently available in the U.K. and Belgium.
